Detalhe da pesquisa
1.
Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial.
Am J Respir Crit Care Med
; 208(3): 256-269, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37154608
2.
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trial.
Trials
; 23(1): 401, 2022 May 13.
Artigo
Inglês
| MEDLINE | ID: mdl-35562778
3.
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial.
EClinicalMedicine
; 41: 101167, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34746723
4.
Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Trials
; 21(1): 462, 2020 Jun 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32493473